IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kala BIO Inc (KALA)

CUSIP: 483119301 | NYSE | 15 institutional holders

Quarters

Q3 2026Q2 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13GLabkowski Nachum966,9915.0%New 5%+ stakeOct 14, 2026No 13F filer matched
13D/ALazar David E.719,4043.9%Newly reportedMay 20, 2026

Institutional Holders — Q3 2026

Geode Capital Management, LLC173,948
0.0% of portfolio›$74.7K
UBS Group AG1,345
0.0% of portfolio›$577
Bank Julius Baer & Co. Ltd, Zurich5
0.0% of portfolio›$0
Barclays PLC1
0.0% of portfolio›$0
Caitong International Asset Management Co., Ltd1
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Geode Capital Management, LLC
173,948$74.7K0.0%IndexVery LowBoston, MA2026-11-06
UBS Group AG
1,345$5770.0%CoreMediumZurich, Switzerland2026-11-10
Bank Julius Baer & Co. Ltd, Zurich
5$00.0%GrowthMediumZurich, Switzerland2026-10-29
Barclays PLC
1$00.0%GrowthMediumLondon, United Kingdom2026-11-06
Caitong International Asset Management Co., Ltd
1$00.0%GrowthVery HighHong Kong, South Korea2026-10-29
No 13F filer matched
13GLabkowski Nachum966,991
5.0% of class · Oct 14, 2026New 5%+ stake
No 13F filer matched
13D/ALazar David E.719,404
3.9% of class · May 20, 2026Newly reported
No 13F filer matched